Insights

API share price (ASX:API) falls after rejecting Wesfarmers takeover offer

API said no deal to Wesfarmers this morning.
The post API share price (ASX:API) falls after rejecting Wesfarmers takeover offer appeared first on The Motley Fool Australia. –

The Australian Pharmaceutical Industries Ltd (ASX: API) share price is in the red after it rejected Wesfarmers Ltd‘s (ASX: WES) takeover offer.

API announced this morning its board has rejected the offer, saying it’s not compelling or in its shareholders’ best interests.

Right now, the API share price is $1.40, 0.35% lower than its previous closing price.

Let’s take a closer look at the news out of API this morning.

Wesfarmers’ offer rejected

The API share price is down today after the company rejected Wesfarmers’ takeover offer of $1.38 cash per share.

The pharmaceutical, health, and beauty-focused company said Wesfarmers’ offer was at an 18.7% premium to API’s 3-month volume weighted average share price. It said that figure is “significantly below the Australian market average for transactions of this nature”.

Additionally, API’s board said the offer was opportunistic given the impact COVID-19 has had on API’s profits.

It also said it failed to take into account the strategic value of Priceline.

According to API, its expecting “substantial” growth in Priceline’s earnings as COVID-19 restrictions lessen and the impact of closing 9 loss-making stores take effect.

It also said Wesfarmers’ offer failed to take into account API’s investment into 39 Clear Skincare clinics and the savings expected from the development of the Marsden Park Distribution Centre.

Finally, it said it expects its pharmaceutical distribution business to get more funding from the 4 years remaining on API’s 7th Community Pharmacy Agreement, as well as its arrangement with Pfizer (which doesn’t include the COVID-19 vaccine).

The Wesfarmers share price is falling alongside that of API this morning.

Currently, shares in Wesfarmers are going for $61.25, 0.49% lower than their previous close.

API share price snapshot

API has been performing well on the ASX lately.

Right now, shares in API are trading for 11.9% more than they were at the start of the year. They’ve also gained 29% since this time last year.

The company has a market capitalisation of around $694 million, with approximately 492 million shares outstanding.

The post API share price (ASX:API) falls after rejecting Wesfarmers takeover offer appeared first on The Motley Fool Australia.

Should you invest $1,000 in API right now?

Before you consider API, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and API wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

Wesfarmers (ASX:WES) share price falls after API rejects takeover offer
Own Wesfarmers (ASX:WES) shares? Here’s what to look for during reporting season
2 ASX shares to hold onto for the next 5 years

Here’s why the Wesfarmers (ASX:WES) share price is up 7% in a month
ASX 200 Weekly Wrap: Just like that… ASX back to record highs

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!